Is Leidos Holdings (LDOS) Undervalued As Its $127 Million Army Contract Extends Growth Visibility?
Leidos Holdings (LDOS) just secured a new U.S. Army award of up to $127 million for its ARTEMIS airborne intelligence system, extending European ISR operations through 2027 and sharpening investor focus on its contract driven profile.
Recent moves have been choppy. The share price has slipped about 12% over the past month and is down roughly 33% year to date, even though the 3 year total shareholder return of about 39% points to a much stronger longer run. This suggests investors are reassessing near term contract risk and execution, while longer term holders remain ahead overall.
Scan contract driven defense and intelligence plays like Leidos Holdings by zeroing in on our hand picked 30 resilient stocks with low risk scores that pair resilience with fundamental strength.
Leidos Holdings now trades well below recent levels even as fresh contracts extend its visibility. Has most of the rerating already played out, or does the current valuation still leave meaningful upside on the table?
Most Popular Narrative: 21% Undervalued
On Simply Wall St’s most followed storyline, Leidos Holdings screens as undervalued, with a fair value estimate of $156.60 against a last close of $123.61. This puts the recent pullback in the context of a longer term earnings and contract thesis rather than just short term price action.
The business mix is shifting towards recurring, service-based and software-driven revenue streams (logistics, health IT, cloud-native platforms), enhancing earnings visibility and stability. This is expected to support higher long-term valuation multiples as the market recognizes improved predictability in cash flow and profit growth.
See why 55 investors see Leidos Holdings as 21% undervalued.
Result: Fair Value of $156.60 (UNDERVALUED)
Still, analyst worries about Leidos Holdings’ dependence on U.S. federal funding and ongoing pressure in the Health segment could quickly weaken that 21% undervaluation narrative.
Find out about the key risks to this Leidos Holdings narrative.
Next Steps
Sentiment on Leidos Holdings is split, with recent price pressure set against a longer term undervaluation story that still has support. Act quickly to weigh both sides of the argument and test the underlying data yourself by reviewing the 5 key rewards and 2 important warning signs.
Looking for more ideas beyond Leidos Holdings?
Do not stop with Leidos Holdings alone. Fresh opportunities often sit just outside your current watchlist, and missing them can quietly drag on long term returns.
- Target quality on sale by scanning companies that look mispriced on fundamentals through the 32 high quality undervalued stocks.
- Strengthen your income stream by reviewing higher yielding payers in the 8 dividend fortresses.
- Prioritize resilience by filtering for sturdier finances and steady operations using the list of solid balance sheet and fundamentals (24 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com